Tanel Kiik
Sotsiaalminister
Sotsiaalministeerium 04.11.2020
nr 10.1-13/1079-1
Austatud härra minister
Edastame Teile Euroopa Komisjoni voliniku Stella Kyriakides’e 04.11.2020 kirja nr
Ares(2020) 6337032 (vaccine preparedness).
Lugupidamisega
Marten Kokk
Esinduse asejuht Coreper I küsimustes
Lisa: voliniku kiri 3 lk
Tiiu Noobel +32 2227 4337
[email protected]
Rue Guimard 11/13 1040 Brüssel Tel: +32 2 227 39 10
[email protected] https://eu.mfa.ee/et/
Tiiu Noobel
From:
[email protected]
Sent: Wednesday, 4 November 2020 13:54
To:
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; Esindus EL
juures üldaadress;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]
Cc:
[email protected];
[email protected]; Roberto.REIG-
[email protected];
[email protected];
[email protected]
Subject: Letter from EU Commissioner Stella Kyriakides to EU Health Ministers on vaccine
preparedness
Attachments: 2020 11 04 Letter from Commissioner Kyriakides to Health Ministers on vaccine
preparedness.pdf; Cover letter to PermReps.pdf
Dear Sir/Madam,
You will find enclosed a letter from the European Commissioner for Health and Food Safety, Mrs Stella Kyriakides,
for the attention of the EU Health Ministers, and the transmission letter addressed to the Ambassadors.
We would be grateful if you could transmit this correspondence to the attention of your respective Minister at your
best convenience.
Sincerely,
CHRISTIANA SOLOMONIDOU
Assistant to Ms Τove Ernst & Ms Karolina Herbout-Borczak
European Commission
Cabinet of Commissioner Stella Kyriakides
Health and Food Safety
BERL 10/400
B-1049 Brussels/Belgium
+32 229-90271
[email protected]
1
Ref. Ares(2020)6337032 - 04/11/2020
STELLA KYRIAKIDES Rue de la Loi, 200
MEMBER OF THE EUROPEAN COMMISSION B-1049 Brussels – Berl 10/380
HEALTH AND FOOD SAFETY
[email protected]
Brussels, 4/11/2020
Dear Minister,
In parallel with our joint efforts to secure access to safe and effective vaccines against
COVID-19 as quickly as possible, we also need to ensure preparedness for the deployment of
such vaccines. Planning ahead is of crucial importance to ensure efficient, effective and
targeted rollouts of the vaccines. I know that you are all actively working on national
COVID-19 vaccination deployment strategies.
To support you in this work, on 15 October we presented the necessary steps to ensure
preparedness for successful and coordinated COVID-19 vaccination strategies1, to ensure
efficient and targeted deployments.
In particular, I would encourage you to consider a number of key elements for a successful
implementation of these strategies, starting with ensuring the capacity of vaccination services
to administer COVID-19 vaccines. At a time of unprecedented pressure on healthcare
systems, we must have the necessary staff with the necessary skills and equipment to do this.
We must ensure that there is easy and safe access to vaccination services for priority and
target populations. Physical distance must not be an obstacle to access vaccines, and the same
applies to price. This is why we recommend making COVID-19 vaccines free of charge and
easily accessible, to ensure they reach every person in the EU.
As the COVID-19 vaccines Steering Board has discussed on several occasions, the
availability of storage and transport facilities that are tailored to the different characteristics
of the vaccine that may become available is essential to the success of this endeavour.
EU Health Ministers
1
https://ec.europa.eu/health/sites/health/files/vaccination/docs/2020_strategies_deployment_en.pdf
This includes cold or cooled storage options to protect the vaccines. All Member States must
put in place the necessary transport and storage capacities.
The pandemic has also shown the importance of data and monitoring. It will be crucial that
you have in place electronic registration of vaccination processes via the Immunisation
Information System. These data can play a key role in safety and effectiveness studies and its
availability across the EU will be important.
We must make sure that there is a pro-active and clear communication with all citizens and in
particular the target populations on COVID-19 vaccines. The European Medicines Agency
will ensure that any COVID-19 vaccine reaching the EU market has been thoroughly
assessed to ensure safety, high quality and effectiveness. This needs to be communicated in a
transparent and factual manner to citizens to combat vaccine hesitancy and gain trust in what
can be a key tool to overcome the pandemic. The Commission is ready to support your efforts
in this area with specific measures to counter misinformation, exchange of good practices and
coordination of messages.
We will also support you to ensure that the vaccines, once available, can be deployed in a
timely fashion. We will develop specific elements for a common deployment strategy,
including for example checklists for different stages of the deployment chain in order to
ensure a coordinated deployment, in collaboration with the Health Security Committee and
the National Immunization Technical Advisory Groups (NITAGs) network coordinated by
European Centre for Disease Prevention and Control (ECDC).
I have asked the ECDC to provide information based on mathematical modelling to help
decisions making regarding vaccine deployment.
In the EU COVID-19 vaccines Strategy, the Commission has committed to ensuring safety
above all other aspects. The European Medicines Agency, together with the ECDC, will
coordinate large-scale EU-wide post-marketing studies to assess the safety and the effectives
of future COVID-19 vaccines. Your support will be crucial to deliver on this commitment
and to ensure that essential, real-world data on the effects and safety aspects of the vaccine
reaches the European level and all other Member States in real time.
We will collaborate with the European Regional Office of the World Health Organization and
the ECDC in order to collect data on vaccine coverage and implementation of national
vaccination strategies, fully respecting the protection of personal data. This will allow us to
have a comprehensive view on the COVID-19 vaccination status in the EU.
Finally, I would also like to remind us all of the need for a precise plan for safe stock-piling
and efficient and effective logistics, in the midst of a pandemic, for vaccines that will require
in the majority of cases two injections. This is a challenge that requires careful planning and I
can only reiterate the Commission’s standing offer to help Member States in this undertaking.
We will not be able to turn the tide from one day to another, not even with a vaccine. But it is
absolutely essential everyone must get ready. It is not vaccines that save lives: vaccinations
do.
In the coming days and weeks, we will be monitoring our collective preparedness on
COVID-19 vaccination, through a continuously updated monitoring document, which I will
be able to share with you in our future correspondence.
I would like to thank you for your continued support and collaboration on these complex but
extremely important aspects of our joint work to fight the pandemic.
Yours sincerely,
Electronically signed on 04/11/2020 13:24 (UTC+01) in accordance with article 11 of Commission Decision C(2020) 4482